We partner with pharma to co-create, and license digital therapies that empower patients globally.

Our treatments reduce the barriers to those seeking medical treatment by providing highly effective and safe therapies targeting untreated symptoms and diseases.


A complete smoking cessation program treating nicotine addiction

The comprehensive DTx will soon be available as a reimbursable prescription DiGA in Germany under the DVG law. The DTx is currently undergoing clinical trial and will be commercialized in collaboration with Pfizer.

In collaboration with:


Prescription DTx to increase quality of life for PF patients.

The comprehensive DTx will provide treatment for currently undertreated symptoms associated with PF, such as low mood and anxiety, improving the patient's quality of life.

In collaboration with:

Alex – Quit Smoking

The all-inclusive digital quit smoking coach.

Currently available for download in over 150 countries globally through the Apple App Store and Google Play.

Go to

Use the Alex DTx Platform to launch novel digital treatments

We partner with pharma, insurance and healthcare companies in developing and launching novel DTx treatments.

Explore our DTx Platform